Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practical issues in adjuvant therapy for rectal cancer.

J J Tjandra1, P Gibbs, M W Chao

  • 1Department of Colorectal Surgery, Royal Melbourne Hospital, University of Melbourne, Australia. tjandra@connexus.net.au

Annals of the Academy of Medicine, Singapore
|May 30, 2003
PubMed
Summary

Adjuvant chemoradiotherapy (CT) and radiation therapy (RT) improve survival for rectal cancer patients. Preoperative therapy shows promise for better outcomes and potentially sphincter preservation, with ongoing trials refining optimal treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).

ESMO real world data and digital oncology·2026
Same author

Real-world characteristics and outcomes of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in Australia: the COALA project.

ESMO real world data and digital oncology·2026
Same author

Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, multicentre, real-world analysis.

ESMO real world data and digital oncology·2026
Same author

Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Early onset metastatic colorectal cancer in Australia.

Cancer treatment and research communications·2024
Same author

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Journal of neuro-oncology·2024

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Standard adjuvant therapy for rectal cancer involves radiation therapy (RT) and chemotherapy (CT).
  • Optimal treatment combinations and sequencing remain under investigation.
  • Recent clinical trials have significantly advanced the field.

Purpose of the Study:

  • To review pivotal trials and recent literature on adjuvant treatment for rectal cancer.
  • To summarize current approaches to adjuvant therapy.
  • To highlight ongoing research defining optimal treatment strategies.

Main Methods:

  • Review of pivotal randomized clinical trials in rectal cancer.
  • Focus on recent literature influencing current adjuvant treatment approaches.

Related Experiment Videos

Main Results:

  • Adjuvant CT and RT reduce local and distant recurrence risk for stage II/III rectal cancer.
  • Combined CT and RT improve overall survival.
  • Preoperative therapy may offer superior results and potentially increase sphincter preservation rates, though further data is pending.

Conclusions:

  • Rectal cancer management is complex, requiring multidisciplinary collaboration.
  • Optimal combinations of CT and RT are being defined by ongoing clinical trials.
  • Preoperative therapy is a promising area for future rectal cancer treatment.